First line chemotherapy with planned sequential administration of gemcitabine followed by docetaxel in elderly advanced non-small-cell lung cancer patients: a ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2008-02

AUTHORS

C Tibaldi, E Vasile, A Antonuzzo, R Di Marsico, A Fabbri, F Innocenti, G Tartarelli, D Amoroso, M Andreuccetti, M Lo Dico, A Falcone

ABSTRACT

This multicenter phase II study evaluated, in chemonaive patients with stage IIIB-IV NSCLC, age >or=70 and with a performance status 0-2, the activity, efficacy and tolerability of planned sequential administration of gemcitabine 1200 mg m(-2) on days 1 and 8 every 3 weeks for three courses followed by three cycles of docetaxel 37.5 mg m(-2) on days 1 and 8 every 3 weeks, provided there was no evidence of disease progression. A total of 56 patients entered the study. According to intention-to-treat analysis, the objective response rate was 16.0% (95% CI 7.6-28.3%); 23 patients (41.0%) had stable disease and 24 patients (43%) had progressive disease. Five patients who had a stable disease after three courses of gemcitabine obtained a conversion to partial response by docetaxel. Median time to progression was 4.8 months (95% CI 3.6-6.0 months) and median duration of survival was 8.0 months (95% CI 5.6-10.5 months). The 1-year survival rate was 34%. No grade 4 haematological toxicity was observed and grade 3 neutropenia and thrombocytopenia were reported in 5.4 and 3.6% of the patients, respectively. Grade 3/4 mucositis and grade 3 diarrhoea, both occurred in 3.6% of the patients and grade 3 asthenia was observed in 9% of patients. One patient reported a grade 4 skin toxicity. No treatment-related deaths occurred. Sequential gemcitabine and docetaxel is a well-tolerated and effective regimen in elderly advanced NSCLC patients. More... »

PAGES

558

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.bjc.6604187

DOI

http://dx.doi.org/10.1038/sj.bjc.6604187

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1012950363

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/18212755


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Non-Small-Cell Lung", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Deoxycytidine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Administration Schedule", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lung Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Taxoids", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Presidio Ospedaliero", 
          "id": "https://www.grid.ac/institutes/grid.440387.c", 
          "name": [
            "Division of Oncology, Department of Oncology, UO Oncologia Medica, Presidio Ospedaliero, Azienda USL-6 of Livorno Viale Alfieri 36, Livorno 57100, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tibaldi", 
        "givenName": "C", 
        "id": "sg:person.0631427704.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0631427704.49"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Presidio Ospedaliero", 
          "id": "https://www.grid.ac/institutes/grid.440387.c", 
          "name": [
            "Division of Oncology, Department of Oncology, UO Oncologia Medica, Presidio Ospedaliero, Azienda USL-6 of Livorno Viale Alfieri 36, Livorno 57100, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Vasile", 
        "givenName": "E", 
        "id": "sg:person.01006607213.66", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01006607213.66"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Oncology Civil Hospital, Via Forlanini 22, Piombino 57025, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Antonuzzo", 
        "givenName": "A", 
        "id": "sg:person.01144410463.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01144410463.37"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Oncology Civil Hospital, Via O. Marrucci 66, Cecina 57023, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Di Marsico", 
        "givenName": "R", 
        "id": "sg:person.01076275263.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01076275263.11"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Division of Pneumology Civil Hospital, Viale Matteotti 35, Pistoia 51100, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fabbri", 
        "givenName": "A", 
        "id": "sg:person.0722546444.94", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0722546444.94"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Division of Pneumology Civil Hospital, Viale Matteotti 35, Pistoia 51100, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Innocenti", 
        "givenName": "F", 
        "id": "sg:person.01257735202.82", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01257735202.82"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Division of Oncology, Department of Oncology Civil Hospital, Via Aurelia 335, Viareggio 55041, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tartarelli", 
        "givenName": "G", 
        "id": "sg:person.01351461042.67", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01351461042.67"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Division of Oncology, Department of Oncology Civil Hospital, Via Aurelia 335, Viareggio 55041, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Amoroso", 
        "givenName": "D", 
        "id": "sg:person.0611155055.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0611155055.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Presidio Ospedaliero", 
          "id": "https://www.grid.ac/institutes/grid.440387.c", 
          "name": [
            "Division of Oncology, Department of Oncology, UO Oncologia Medica, Presidio Ospedaliero, Azienda USL-6 of Livorno Viale Alfieri 36, Livorno 57100, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Andreuccetti", 
        "givenName": "M", 
        "id": "sg:person.01210274354.56", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01210274354.56"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Presidio Ospedaliero", 
          "id": "https://www.grid.ac/institutes/grid.440387.c", 
          "name": [
            "Division of Oncology, Department of Oncology, UO Oncologia Medica, Presidio Ospedaliero, Azienda USL-6 of Livorno Viale Alfieri 36, Livorno 57100, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dico", 
        "givenName": "M Lo", 
        "id": "sg:person.07575135056.74", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07575135056.74"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Pisa", 
          "id": "https://www.grid.ac/institutes/grid.5395.a", 
          "name": [
            "Division of Oncology, Department of Oncology, UO Oncologia Medica, Presidio Ospedaliero, Azienda USL-6 of Livorno Viale Alfieri 36, Livorno 57100, Italy", 
            "Department of Oncology, University of Pisa Via Roma 67, Pisa 56100, Italy", 
            "Istituto Toscano Tumori (ITT) Via Taddeo Alderotti 26/N, Firenze 50139, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Falcone", 
        "givenName": "A", 
        "id": "sg:person.01006230145.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01006230145.44"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1200/jco.2006.06.1044", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000413172"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2005.04.4859", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000963905"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1556-0864(15)30356-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004139329"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.critrevonc.2005.06.003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006505460"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.critrevonc.2005.06.003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006505460"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6602241", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008698049", 
          "https://doi.org/10.1038/sj.bjc.6602241"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6602241", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008698049", 
          "https://doi.org/10.1038/sj.bjc.6602241"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdj115", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010021328"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.lungcan.2004.10.008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014262044"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2004.06.920", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015913137"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/94.3.173", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015947313"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/jto.0b013e318031cd62", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016045507"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2004.09.053", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017113154"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2005.02.3739", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017456843"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2005.02.3739", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017456843"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2005.02.527", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019698641"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.critrevonc.2007.06.008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020840737"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0021-9681(87)90171-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020988115"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2006.10.3085", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027226602"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(00)04644-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027922703"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdi126", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030387211"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/1097-0142(19941001)74:7+<2101::aid-cncr2820741718>3.0.co;2-m", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031883808"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/92.3.205", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032301848"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3816/clc.2006.n.024", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033968801"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/95.5.362", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042535498"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.lungcan.2004.05.015", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044713200"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0761-8425(06)71596-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047839957"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2005.07.172", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049586247"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2005.04.016", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050993603"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01243894-200607000-00007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060334518"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2003.12.046", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064204000"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2000.18.10.2095", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074640407"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2000.18.12.2354", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074654615"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079921416", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1081425990", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2008-02", 
    "datePublishedReg": "2008-02-01", 
    "description": "This multicenter phase II study evaluated, in chemonaive patients with stage IIIB-IV NSCLC, age >or=70 and with a performance status 0-2, the activity, efficacy and tolerability of planned sequential administration of gemcitabine 1200 mg m(-2) on days 1 and 8 every 3 weeks for three courses followed by three cycles of docetaxel 37.5 mg m(-2) on days 1 and 8 every 3 weeks, provided there was no evidence of disease progression. A total of 56 patients entered the study. According to intention-to-treat analysis, the objective response rate was 16.0% (95% CI 7.6-28.3%); 23 patients (41.0%) had stable disease and 24 patients (43%) had progressive disease. Five patients who had a stable disease after three courses of gemcitabine obtained a conversion to partial response by docetaxel. Median time to progression was 4.8 months (95% CI 3.6-6.0 months) and median duration of survival was 8.0 months (95% CI 5.6-10.5 months). The 1-year survival rate was 34%. No grade 4 haematological toxicity was observed and grade 3 neutropenia and thrombocytopenia were reported in 5.4 and 3.6% of the patients, respectively. Grade 3/4 mucositis and grade 3 diarrhoea, both occurred in 3.6% of the patients and grade 3 asthenia was observed in 9% of patients. One patient reported a grade 4 skin toxicity. No treatment-related deaths occurred. Sequential gemcitabine and docetaxel is a well-tolerated and effective regimen in elderly advanced NSCLC patients.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/sj.bjc.6604187", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1017082", 
        "issn": [
          "0007-0920", 
          "1532-1827"
        ], 
        "name": "British Journal of Cancer", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "98"
      }
    ], 
    "name": "First line chemotherapy with planned sequential administration of gemcitabine followed by docetaxel in elderly advanced non-small-cell lung cancer patients: a multicenter phase II study", 
    "pagination": "558", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "3db26b134e56d494e962db6e699ba4f6eb1eba20f8fbc79647a75dba0569e79c"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "18212755"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0370635"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.bjc.6604187"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1012950363"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.bjc.6604187", 
      "https://app.dimensions.ai/details/publication/pub.1012950363"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T15:38", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8664_00000422.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://www.nature.com/articles/6604187"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6604187'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6604187'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6604187'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6604187'


 

This table displays all metadata directly associated to this object as RDF triples.

299 TRIPLES      21 PREDICATES      73 URIs      33 LITERALS      21 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.bjc.6604187 schema:about N25428594457f433b818f392327ec5653
2 N48efcd4096254d6590cf08edfdae6d75
3 N497161dfafe0471b9af296f1de5f7261
4 N4d6b047f52a84dd08b5fddc068f4fb0d
5 N5d8ab7dd941645abbb45c5b887dc8c64
6 N861061ff523e447ba37bea1cddb2ac12
7 N976e6fb7917a4d038780c5a095a4627b
8 N97969a9e9565425a811bc1bd6fc1c0f6
9 Nac95d73740f642a2b45ab00cccf799d0
10 Nbe3a1cc7ad474480b0d4d4fec310c845
11 Nd0204578349343f1a3bee371b371bdd1
12 Nf91b0f7e33a944e3afa4a971f7d6164f
13 anzsrc-for:11
14 anzsrc-for:1103
15 schema:author N5a9c3285fe7844feb1c052104772cf22
16 schema:citation sg:pub.10.1038/sj.bjc.6602241
17 https://app.dimensions.ai/details/publication/pub.1079921416
18 https://app.dimensions.ai/details/publication/pub.1081425990
19 https://doi.org/10.1002/1097-0142(19941001)74:7+<2101::aid-cncr2820741718>3.0.co;2-m
20 https://doi.org/10.1016/0021-9681(87)90171-8
21 https://doi.org/10.1016/j.critrevonc.2005.06.003
22 https://doi.org/10.1016/j.critrevonc.2007.06.008
23 https://doi.org/10.1016/j.lungcan.2004.05.015
24 https://doi.org/10.1016/j.lungcan.2004.10.008
25 https://doi.org/10.1016/s0140-6736(00)04644-4
26 https://doi.org/10.1016/s0761-8425(06)71596-0
27 https://doi.org/10.1016/s1556-0864(15)30356-7
28 https://doi.org/10.1093/annonc/mdi126
29 https://doi.org/10.1093/annonc/mdj115
30 https://doi.org/10.1093/jnci/92.3.205
31 https://doi.org/10.1093/jnci/94.3.173
32 https://doi.org/10.1093/jnci/95.5.362
33 https://doi.org/10.1097/01243894-200607000-00007
34 https://doi.org/10.1097/jto.0b013e318031cd62
35 https://doi.org/10.1200/jco.2000.18.10.2095
36 https://doi.org/10.1200/jco.2000.18.12.2354
37 https://doi.org/10.1200/jco.2003.12.046
38 https://doi.org/10.1200/jco.2004.06.920
39 https://doi.org/10.1200/jco.2004.09.053
40 https://doi.org/10.1200/jco.2005.02.3739
41 https://doi.org/10.1200/jco.2005.02.527
42 https://doi.org/10.1200/jco.2005.04.016
43 https://doi.org/10.1200/jco.2005.04.4859
44 https://doi.org/10.1200/jco.2005.07.172
45 https://doi.org/10.1200/jco.2006.06.1044
46 https://doi.org/10.1200/jco.2006.10.3085
47 https://doi.org/10.3816/clc.2006.n.024
48 schema:datePublished 2008-02
49 schema:datePublishedReg 2008-02-01
50 schema:description This multicenter phase II study evaluated, in chemonaive patients with stage IIIB-IV NSCLC, age >or=70 and with a performance status 0-2, the activity, efficacy and tolerability of planned sequential administration of gemcitabine 1200 mg m(-2) on days 1 and 8 every 3 weeks for three courses followed by three cycles of docetaxel 37.5 mg m(-2) on days 1 and 8 every 3 weeks, provided there was no evidence of disease progression. A total of 56 patients entered the study. According to intention-to-treat analysis, the objective response rate was 16.0% (95% CI 7.6-28.3%); 23 patients (41.0%) had stable disease and 24 patients (43%) had progressive disease. Five patients who had a stable disease after three courses of gemcitabine obtained a conversion to partial response by docetaxel. Median time to progression was 4.8 months (95% CI 3.6-6.0 months) and median duration of survival was 8.0 months (95% CI 5.6-10.5 months). The 1-year survival rate was 34%. No grade 4 haematological toxicity was observed and grade 3 neutropenia and thrombocytopenia were reported in 5.4 and 3.6% of the patients, respectively. Grade 3/4 mucositis and grade 3 diarrhoea, both occurred in 3.6% of the patients and grade 3 asthenia was observed in 9% of patients. One patient reported a grade 4 skin toxicity. No treatment-related deaths occurred. Sequential gemcitabine and docetaxel is a well-tolerated and effective regimen in elderly advanced NSCLC patients.
51 schema:genre research_article
52 schema:inLanguage en
53 schema:isAccessibleForFree true
54 schema:isPartOf N69d145da91f54c348547d8a2010cd7e9
55 Nf253228e971b49229b741047bdb71950
56 sg:journal.1017082
57 schema:name First line chemotherapy with planned sequential administration of gemcitabine followed by docetaxel in elderly advanced non-small-cell lung cancer patients: a multicenter phase II study
58 schema:pagination 558
59 schema:productId N12c89526dd0347d9bd5c2122fe12207c
60 N23add2a2cb14428aa06b5bcf387fe85f
61 N6321a7506a794e4ca40725aec536cb5c
62 Na1efebf7bf674c998a4504aee33164ae
63 Nffb5a5b74f904ed9a9f3a548c8f01504
64 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012950363
65 https://doi.org/10.1038/sj.bjc.6604187
66 schema:sdDatePublished 2019-04-10T15:38
67 schema:sdLicense https://scigraph.springernature.com/explorer/license/
68 schema:sdPublisher N8434f918bf104fb7a90b650c2ec7347d
69 schema:url https://www.nature.com/articles/6604187
70 sgo:license sg:explorer/license/
71 sgo:sdDataset articles
72 rdf:type schema:ScholarlyArticle
73 N12c89526dd0347d9bd5c2122fe12207c schema:name pubmed_id
74 schema:value 18212755
75 rdf:type schema:PropertyValue
76 N20ab8264ffef429895e89c0bb7fe5c81 rdf:first sg:person.01210274354.56
77 rdf:rest N670505e4c0cd44cb93728f66fc30ce84
78 N23add2a2cb14428aa06b5bcf387fe85f schema:name doi
79 schema:value 10.1038/sj.bjc.6604187
80 rdf:type schema:PropertyValue
81 N25428594457f433b818f392327ec5653 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
82 schema:name Female
83 rdf:type schema:DefinedTerm
84 N2701b7fc2bf94b5db946fe8d6f3c5744 schema:name Division of Oncology, Department of Oncology Civil Hospital, Via Aurelia 335, Viareggio 55041, Italy
85 rdf:type schema:Organization
86 N3e03ecb34d2847988b9a95dd324fb3cf rdf:first sg:person.01144410463.37
87 rdf:rest Nb20c3c88d77f47c49bf22c976f6f3063
88 N461c99335b3643efa75e6afc058970f0 schema:name Department of Oncology Civil Hospital, Via O. Marrucci 66, Cecina 57023, Italy
89 rdf:type schema:Organization
90 N4724eccefbed40198c62ea7e9bda8ffe schema:name Division of Pneumology Civil Hospital, Viale Matteotti 35, Pistoia 51100, Italy
91 rdf:type schema:Organization
92 N48efcd4096254d6590cf08edfdae6d75 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Survival Analysis
94 rdf:type schema:DefinedTerm
95 N497161dfafe0471b9af296f1de5f7261 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Aged
97 rdf:type schema:DefinedTerm
98 N4d6b047f52a84dd08b5fddc068f4fb0d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Lung Neoplasms
100 rdf:type schema:DefinedTerm
101 N5a9c3285fe7844feb1c052104772cf22 rdf:first sg:person.0631427704.49
102 rdf:rest Nd2558bdc70fd4dd3a9363f81766ef86c
103 N5d8ab7dd941645abbb45c5b887dc8c64 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Deoxycytidine
105 rdf:type schema:DefinedTerm
106 N6321a7506a794e4ca40725aec536cb5c schema:name readcube_id
107 schema:value 3db26b134e56d494e962db6e699ba4f6eb1eba20f8fbc79647a75dba0569e79c
108 rdf:type schema:PropertyValue
109 N670505e4c0cd44cb93728f66fc30ce84 rdf:first sg:person.07575135056.74
110 rdf:rest N8fe5badeaf58470c90e24ab03be9e9d3
111 N69d145da91f54c348547d8a2010cd7e9 schema:volumeNumber 98
112 rdf:type schema:PublicationVolume
113 N8434f918bf104fb7a90b650c2ec7347d schema:name Springer Nature - SN SciGraph project
114 rdf:type schema:Organization
115 N861061ff523e447ba37bea1cddb2ac12 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Carcinoma, Non-Small-Cell Lung
117 rdf:type schema:DefinedTerm
118 N8fe5badeaf58470c90e24ab03be9e9d3 rdf:first sg:person.01006230145.44
119 rdf:rest rdf:nil
120 N90270c12e3b34e9aada1cb4f6b1729de schema:name Division of Oncology, Department of Oncology Civil Hospital, Via Aurelia 335, Viareggio 55041, Italy
121 rdf:type schema:Organization
122 N976e6fb7917a4d038780c5a095a4627b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Male
124 rdf:type schema:DefinedTerm
125 N97969a9e9565425a811bc1bd6fc1c0f6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Humans
127 rdf:type schema:DefinedTerm
128 Na1efebf7bf674c998a4504aee33164ae schema:name nlm_unique_id
129 schema:value 0370635
130 rdf:type schema:PropertyValue
131 Nac95d73740f642a2b45ab00cccf799d0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Aged, 80 and over
133 rdf:type schema:DefinedTerm
134 Nb16b44d4b5cf44bcb937b289057cf54f rdf:first sg:person.0611155055.35
135 rdf:rest N20ab8264ffef429895e89c0bb7fe5c81
136 Nb20c3c88d77f47c49bf22c976f6f3063 rdf:first sg:person.01076275263.11
137 rdf:rest Ne1a29fd0b77d4cbabf43b61b30ee4391
138 Nbe3a1cc7ad474480b0d4d4fec310c845 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Antineoplastic Combined Chemotherapy Protocols
140 rdf:type schema:DefinedTerm
141 Ncfe9567ce43b4a5b9f728a6c50fb76f0 rdf:first sg:person.01351461042.67
142 rdf:rest Nb16b44d4b5cf44bcb937b289057cf54f
143 Nd0204578349343f1a3bee371b371bdd1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Taxoids
145 rdf:type schema:DefinedTerm
146 Nd2558bdc70fd4dd3a9363f81766ef86c rdf:first sg:person.01006607213.66
147 rdf:rest N3e03ecb34d2847988b9a95dd324fb3cf
148 Ne18ead0bbc81426081c8bdd6882847a3 rdf:first sg:person.01257735202.82
149 rdf:rest Ncfe9567ce43b4a5b9f728a6c50fb76f0
150 Ne1a29fd0b77d4cbabf43b61b30ee4391 rdf:first sg:person.0722546444.94
151 rdf:rest Ne18ead0bbc81426081c8bdd6882847a3
152 Nf253228e971b49229b741047bdb71950 schema:issueNumber 3
153 rdf:type schema:PublicationIssue
154 Nf54f9458371d466dba86afdc5d4160c6 schema:name Division of Pneumology Civil Hospital, Viale Matteotti 35, Pistoia 51100, Italy
155 rdf:type schema:Organization
156 Nf91b0f7e33a944e3afa4a971f7d6164f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Drug Administration Schedule
158 rdf:type schema:DefinedTerm
159 Nfa4febaadefe4e5da9f2f962ba1196b0 schema:name Department of Oncology Civil Hospital, Via Forlanini 22, Piombino 57025, Italy
160 rdf:type schema:Organization
161 Nffb5a5b74f904ed9a9f3a548c8f01504 schema:name dimensions_id
162 schema:value pub.1012950363
163 rdf:type schema:PropertyValue
164 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
165 schema:name Medical and Health Sciences
166 rdf:type schema:DefinedTerm
167 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
168 schema:name Clinical Sciences
169 rdf:type schema:DefinedTerm
170 sg:journal.1017082 schema:issn 0007-0920
171 1532-1827
172 schema:name British Journal of Cancer
173 rdf:type schema:Periodical
174 sg:person.01006230145.44 schema:affiliation https://www.grid.ac/institutes/grid.5395.a
175 schema:familyName Falcone
176 schema:givenName A
177 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01006230145.44
178 rdf:type schema:Person
179 sg:person.01006607213.66 schema:affiliation https://www.grid.ac/institutes/grid.440387.c
180 schema:familyName Vasile
181 schema:givenName E
182 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01006607213.66
183 rdf:type schema:Person
184 sg:person.01076275263.11 schema:affiliation N461c99335b3643efa75e6afc058970f0
185 schema:familyName Di Marsico
186 schema:givenName R
187 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01076275263.11
188 rdf:type schema:Person
189 sg:person.01144410463.37 schema:affiliation Nfa4febaadefe4e5da9f2f962ba1196b0
190 schema:familyName Antonuzzo
191 schema:givenName A
192 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01144410463.37
193 rdf:type schema:Person
194 sg:person.01210274354.56 schema:affiliation https://www.grid.ac/institutes/grid.440387.c
195 schema:familyName Andreuccetti
196 schema:givenName M
197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01210274354.56
198 rdf:type schema:Person
199 sg:person.01257735202.82 schema:affiliation N4724eccefbed40198c62ea7e9bda8ffe
200 schema:familyName Innocenti
201 schema:givenName F
202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01257735202.82
203 rdf:type schema:Person
204 sg:person.01351461042.67 schema:affiliation N2701b7fc2bf94b5db946fe8d6f3c5744
205 schema:familyName Tartarelli
206 schema:givenName G
207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01351461042.67
208 rdf:type schema:Person
209 sg:person.0611155055.35 schema:affiliation N90270c12e3b34e9aada1cb4f6b1729de
210 schema:familyName Amoroso
211 schema:givenName D
212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0611155055.35
213 rdf:type schema:Person
214 sg:person.0631427704.49 schema:affiliation https://www.grid.ac/institutes/grid.440387.c
215 schema:familyName Tibaldi
216 schema:givenName C
217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0631427704.49
218 rdf:type schema:Person
219 sg:person.0722546444.94 schema:affiliation Nf54f9458371d466dba86afdc5d4160c6
220 schema:familyName Fabbri
221 schema:givenName A
222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0722546444.94
223 rdf:type schema:Person
224 sg:person.07575135056.74 schema:affiliation https://www.grid.ac/institutes/grid.440387.c
225 schema:familyName Dico
226 schema:givenName M Lo
227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07575135056.74
228 rdf:type schema:Person
229 sg:pub.10.1038/sj.bjc.6602241 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008698049
230 https://doi.org/10.1038/sj.bjc.6602241
231 rdf:type schema:CreativeWork
232 https://app.dimensions.ai/details/publication/pub.1079921416 schema:CreativeWork
233 https://app.dimensions.ai/details/publication/pub.1081425990 schema:CreativeWork
234 https://doi.org/10.1002/1097-0142(19941001)74:7+<2101::aid-cncr2820741718>3.0.co;2-m schema:sameAs https://app.dimensions.ai/details/publication/pub.1031883808
235 rdf:type schema:CreativeWork
236 https://doi.org/10.1016/0021-9681(87)90171-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020988115
237 rdf:type schema:CreativeWork
238 https://doi.org/10.1016/j.critrevonc.2005.06.003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006505460
239 rdf:type schema:CreativeWork
240 https://doi.org/10.1016/j.critrevonc.2007.06.008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020840737
241 rdf:type schema:CreativeWork
242 https://doi.org/10.1016/j.lungcan.2004.05.015 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044713200
243 rdf:type schema:CreativeWork
244 https://doi.org/10.1016/j.lungcan.2004.10.008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014262044
245 rdf:type schema:CreativeWork
246 https://doi.org/10.1016/s0140-6736(00)04644-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027922703
247 rdf:type schema:CreativeWork
248 https://doi.org/10.1016/s0761-8425(06)71596-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047839957
249 rdf:type schema:CreativeWork
250 https://doi.org/10.1016/s1556-0864(15)30356-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004139329
251 rdf:type schema:CreativeWork
252 https://doi.org/10.1093/annonc/mdi126 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030387211
253 rdf:type schema:CreativeWork
254 https://doi.org/10.1093/annonc/mdj115 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010021328
255 rdf:type schema:CreativeWork
256 https://doi.org/10.1093/jnci/92.3.205 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032301848
257 rdf:type schema:CreativeWork
258 https://doi.org/10.1093/jnci/94.3.173 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015947313
259 rdf:type schema:CreativeWork
260 https://doi.org/10.1093/jnci/95.5.362 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042535498
261 rdf:type schema:CreativeWork
262 https://doi.org/10.1097/01243894-200607000-00007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1060334518
263 rdf:type schema:CreativeWork
264 https://doi.org/10.1097/jto.0b013e318031cd62 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016045507
265 rdf:type schema:CreativeWork
266 https://doi.org/10.1200/jco.2000.18.10.2095 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074640407
267 rdf:type schema:CreativeWork
268 https://doi.org/10.1200/jco.2000.18.12.2354 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074654615
269 rdf:type schema:CreativeWork
270 https://doi.org/10.1200/jco.2003.12.046 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064204000
271 rdf:type schema:CreativeWork
272 https://doi.org/10.1200/jco.2004.06.920 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015913137
273 rdf:type schema:CreativeWork
274 https://doi.org/10.1200/jco.2004.09.053 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017113154
275 rdf:type schema:CreativeWork
276 https://doi.org/10.1200/jco.2005.02.3739 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017456843
277 rdf:type schema:CreativeWork
278 https://doi.org/10.1200/jco.2005.02.527 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019698641
279 rdf:type schema:CreativeWork
280 https://doi.org/10.1200/jco.2005.04.016 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050993603
281 rdf:type schema:CreativeWork
282 https://doi.org/10.1200/jco.2005.04.4859 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000963905
283 rdf:type schema:CreativeWork
284 https://doi.org/10.1200/jco.2005.07.172 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049586247
285 rdf:type schema:CreativeWork
286 https://doi.org/10.1200/jco.2006.06.1044 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000413172
287 rdf:type schema:CreativeWork
288 https://doi.org/10.1200/jco.2006.10.3085 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027226602
289 rdf:type schema:CreativeWork
290 https://doi.org/10.3816/clc.2006.n.024 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033968801
291 rdf:type schema:CreativeWork
292 https://www.grid.ac/institutes/grid.440387.c schema:alternateName Presidio Ospedaliero
293 schema:name Division of Oncology, Department of Oncology, UO Oncologia Medica, Presidio Ospedaliero, Azienda USL-6 of Livorno Viale Alfieri 36, Livorno 57100, Italy
294 rdf:type schema:Organization
295 https://www.grid.ac/institutes/grid.5395.a schema:alternateName University of Pisa
296 schema:name Department of Oncology, University of Pisa Via Roma 67, Pisa 56100, Italy
297 Division of Oncology, Department of Oncology, UO Oncologia Medica, Presidio Ospedaliero, Azienda USL-6 of Livorno Viale Alfieri 36, Livorno 57100, Italy
298 Istituto Toscano Tumori (ITT) Via Taddeo Alderotti 26/N, Firenze 50139, Italy
299 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...